Francis P Worden - JoVE Visualize

Showing results (31-40 of 133) with videos related to

Pageof 14

Sort By:

Cancer|June 17, 2006

A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007Francis P Worden, James Moon, Wolfram Samlowski, et al.

The Journal of Clinical Endocrinology and Metabolism|June 29, 2024

A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid CarcinomaKartik Sehgal, Anthony Serritella, Mofei Liu, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 6, 2008

Phase II study of celecoxib and docetaxel in non-small cell lung cancer (NSCLC) patients with progression after platinum-based therapyBryan J Schneider, Gregory P Kalemkerian, Michael J Kraut, et al.

Journal of Thyroid Disorders & Therapy|April 19, 2016

Retrospective Study of Sirolimus and Cyclophosphamide in Patients with Advanced Differentiated Thyroid CancersPoorni M Manohar, Lauren J Beesley, Jeremy Mg Taylor, et al.

Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]|September 3, 2010

Sinonasal undifferentiated carcinoma: a 13-year experience at a single institutionErin M Lin, Anthony Sparano, Aaron Spalding, et al.

Translational Oncology|August 31, 2014

Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratioAron Popovtzer, Daniel Normolle, Francis P Worden, et al.

Theranostics|July 1, 2024

Enhancing precision: A predictive model for <sup>177</sup>Lu-DOTATATE treatment response in neuroendocrine tumors using quantitative <sup>68</sup>Ga-DOTATATE PET and clinicopathological biomarkersAzadeh Akhavanallaf, Sonal Joshi, Arathi Mohan, et al.

Journal of Reconstructive Microsurgery|October 25, 2012

Osteocutaneous free tissue transplantation for mandibular osteoradionecrosisShamir P Chandarana, Eric J P Chanowski, Keith A Casper, et al.

Cancer|April 28, 2007

Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcomaRashmi Chugh, Thomas Wagner, Kent A Griffith, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004

Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcomaFrancis P Worden, Jeremy M G Taylor, Janet S Biermann, et al.

Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:

Pageof 14

Cancer|June 17, 2006

A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007Francis P Worden, James Moon, Wolfram Samlowski, et al.

The Journal of Clinical Endocrinology and Metabolism|June 29, 2024

A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid CarcinomaKartik Sehgal, Anthony Serritella, Mofei Liu, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 6, 2008

Phase II study of celecoxib and docetaxel in non-small cell lung cancer (NSCLC) patients with progression after platinum-based therapyBryan J Schneider, Gregory P Kalemkerian, Michael J Kraut, et al.

Journal of Thyroid Disorders & Therapy|April 19, 2016

Retrospective Study of Sirolimus and Cyclophosphamide in Patients with Advanced Differentiated Thyroid CancersPoorni M Manohar, Lauren J Beesley, Jeremy Mg Taylor, et al.

Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]|September 3, 2010

Sinonasal undifferentiated carcinoma: a 13-year experience at a single institutionErin M Lin, Anthony Sparano, Aaron Spalding, et al.

Translational Oncology|August 31, 2014

Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratioAron Popovtzer, Daniel Normolle, Francis P Worden, et al.

Theranostics|July 1, 2024

Enhancing precision: A predictive model for <sup>177</sup>Lu-DOTATATE treatment response in neuroendocrine tumors using quantitative <sup>68</sup>Ga-DOTATATE PET and clinicopathological biomarkersAzadeh Akhavanallaf, Sonal Joshi, Arathi Mohan, et al.

Journal of Reconstructive Microsurgery|October 25, 2012

Osteocutaneous free tissue transplantation for mandibular osteoradionecrosisShamir P Chandarana, Eric J P Chanowski, Keith A Casper, et al.

Cancer|April 28, 2007

Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcomaRashmi Chugh, Thomas Wagner, Kent A Griffith, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004

Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcomaFrancis P Worden, Jeremy M G Taylor, Janet S Biermann, et al.

Pageof 14